Dr Reddys Labs concludes acquisition of Mayne Pharma’s US generic prescription product portfolio
Hyderabad: Pharma major, Dr Reddys Labs, has recently announced that the company has completed the acquisition of Mayne Pharma’s U.S. generic prescription product portfolio. The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health. For the financial period ended June […] More